r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

DB

Donald A. Bergstrom

Insider · President, R&D · RLAY

Donald A. Bergstrom files insider transactions with the SEC as a president, r&d of Relay Therapeutics (RLAY). We hold 6 disclosed purchases and sales filed since 6 February 2018, 3 of them in the last 90 days.

  • Files forRLAY
  • Disclosed buys and sells6 in all, 3 in the last 90 days
  • Last disclosure30 July 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 11 December 2020 — 28 July 2026President, R&D · Relay Therapeutics (RLAY)112 Form 4 lines · source: SEC Form 4
  • Filed 1 April 2021 — 4 June 2024Director · Fusion Pharmaceuticals (FUSN)8 Form 4 lines · source: SEC Form 4
  • Filed 2 February 2018 — 2 February 2018Chief Medical Officer · Mersana Therapeutics (MRSN)1 Form 4 line · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.